臨床試験機器・補助ソリューション市場規模、シェア、動向分析レポート：製品別、フェーズ別、地域別、セグメント予測、2024年～2030年

臨床試験機器・補助ソリューション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験機器・補助ソリューション市場規模は、2024年から2030年にかけてCAGR 8.1％で拡大し、2030年には51億米ドルに達する見込みです。

製薬・医療分野の成長、臨床試験の世界化、研究開発費の増加が市場を牽引する要因です。しかし、COVID-19のパンデミックは世界市場に影響を及ぼし、その結果、機器＆補助用品のサプライチェーンが減速しています。COVID-19パンデミックは臨床試験環境に大きな変化をもたらしました。COVID-19のパンデミックにより世界的に臨床試験が中断される以前は、何百もの臨床試験が進行中でした。しかし、新しくより良い治療法に対する需要の高まりは、パンデミック後の臨床試験の数を増加させました。

臨床試験の手順は近年かなり進化しています。複雑な臨床試験は、ヘルスケアのサプライチェーン全体に新たな問題を引き起こしています。最新の調査では、膨大な数の患者や患者サブグループ、さらに多数の国や研究施設が関与することが頻繁にあります。その結果、サプライチェーンマネージャーが臨床試験機器や付帯設備に取り組む際に直面する課題が増加しています。医療機器のレンタルは、保管、回収、廃棄の負担を軽減します。もう一つの重要な意思決定理由は、機器をレンタルすることで、認可を受けた臨床試験実施場所に必要な多額の初期費用と多額の投資を削減できることです。

パンデミックは、効果的な治療法や介入策に対するニーズを生み出しました。COVID-19は臨床試験の実施方法を変え、ヘルスケアのデジタル化と最先端技術・手法の採用を促しています。このような採用は市場の成長を促進すると思われます。さらに、COVID-19の革新的な治療法を開発するために製薬会社が高い研究開発費を投じていることも、市場の成長にさらに貢献しています。

臨床試験機器・補助ソリューション市場のレポートハイライト

• 供給/物流製品セグメントは、世界的に臨床試験数が多く、効率的な物流サービスに対する需要が増加したため、2023年の収益シェアが38.95%以上で市場を独占しました。
• 第III相セグメントは2023年に市場を独占し、2030年までその優位性を維持すると予想されます。第III相試験は、新たな治療基準を発見するための最も効果的なアプローチです。
• 北米は2022年に世界市場をリードし、同地域のCROや製薬・医療企業の増加により、予測期間中も優位性を維持するとみられます。
• アジア太平洋地域は、臨床試験の実施場所としてますます重要性を増していることから、予測期間中に臨床試験機器および付帯ソリューション市場で最も速い成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験機器・補助ソリューション市場変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 臨床試験機器・補助ソリューション市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 臨床試験機器・補助ソリューション市場：製品推定・動向分析

• 製品市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界の臨床試験機器・補助ソリューション市場、製品展望別
• 市場規模、予測および動向分析、2018年から2030年まで
  • ソーシング
  • サプライ・ロジスティクス
  • サービス
  • その他

第5章 臨床試験機器・補助ソリューション市場：段階推定・動向分析

• フェーズ市場シェア、2023年および2030年
• セグメントダッシュボード
• 世界の臨床試験機器・補助ソリューション市場、フェーズ別の見通し
• 市場規模、予測および動向分析、2018年から2030年まで
  • フェーズ1
  • フェーズ2
  • フェーズ3
  • フェーズ4
  • その他

第6章 臨床試験機器・補助ソリューション市場：地域推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 2018年から2030年の市場規模と予測および動向分析：
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Ancillare, LP
  • Imperial CRS, Inc.
  • Woodley Equipment Company Ltd.
  • Thermo Fisher Scientific, Inc.
  • Parexel International（MA）Corporation
  • Emsere（MediCapital Rent）
  • Quipment SAS
  • IRM
  • Marken
  • Myonex
  • Yourway

List of Tables

• Table 1 List of abbreviations
• Table 2 North America clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
• Table 3 North America clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 4 North America clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 5 U.S. clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 6 U.S. clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 7 Canada clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 8 Canada clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 9 Europe clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
• Table 10 Europe clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 11 Europe clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 12 Germany clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 13 Germany clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 14 UK clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 15 UK clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 16 France clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 17 France clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 18 Italy clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 19 Italy clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 22 Denmark clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 23 Denmark clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 24 Sweden clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 25 Sweden clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 26 Norway clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 27 Norway clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
• Table 29 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 30 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 31 China clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 32 China clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 35 India clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 36 India clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 39 Australia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 40 Australia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 41 Thailand clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 42 Thailand clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 43 Latin America clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
• Table 44 Latin America clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 45 Latin America clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 46 Brazil clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 47 Brazil clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 48 Mexico clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 49 Mexico clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 50 Argentina clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 51 Argentina clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 52 Colombia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 53 Colombia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 54 MEA clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
• Table 55 MEA clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 56 MEA clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 57 South Africa clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 58 South Africa clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 59 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 60 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 61 UAE clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 62 UAE clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
• Table 63 Kuwait clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
• Table 64 Kuwait clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Clinical trial equipment & ancillary solutions market: Market outlook
• Fig. 14 Clinical trial equipment & ancillary solutions market: Competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Clinical trial equipment & ancillary solutions market driver impact
• Fig. 20 Clinical trial equipment & ancillary solutions market restraint impact
• Fig. 21 Clinical trial equipment & ancillary solutions market strategic initiatives analysis
• Fig. 22 Clinical trial equipment & ancillary solutions market: Product movement analysis
• Fig. 23 Clinical trial equipment & ancillary solutions market: Product outlook and key takeaways
• Fig. 24 Sourcing market estimates and forecast, 2018 - 2030
• Fig. 25 Procurement market estimates and forecast, 2018 - 2030
• Fig. 26 Equipment market estimates and forecast, 2018 - 2030
• Fig. 27 Ancillaries market estimates and forecast, 2018 - 2030
• Fig. 28 Rental market estimates and forecast, 2018 - 2030
• Fig. 29 Equipment market estimates and forecast, 2018 - 2030
• Fig. 30 Ancillaries market estimates and forecast, 2018 - 2030
• Fig. 31 Supply/Logistics market estimates and forecast, 2018 - 2030
• Fig. 32 Transportation market estimates and forecast, 2018 - 2030
• Fig. 33 Packaging market estimates and forecast, 2018 - 2030
• Fig. 34 Others market estimates and forecast, 2018 - 2030
• Fig. 35 Service market estimates and forecast, 2018 - 2030
• Fig. 36 Calibrations market estimates and forecast, 2018 - 2030
• Fig. 37 Equipment servicing market estimates and forecast, 2018 - 2030
• Fig. 38 Others market estimates and forecast, 2018 - 2030
• Fig. 39 Other products market estimates and forecast, 2018 - 2030
• Fig. 40 Clinical trial equipment & ancillary solutions market: phase movement analysis
• Fig. 41 Clinical trial equipment & ancillary solutions market: phase outlook and key takeaways
• Fig. 42 Phase I market estimates and forecasts, 2018 - 2030
• Fig. 43 Phase II market estimates and forecasts, 2018 - 2030
• Fig. 44 Phase III market estimates and forecasts, 2018 - 2030
• Fig. 45 Phase IV market estimates and forecasts, 2018 - 2030
• Fig. 46 Global clinical trial equipment & ancillary solutions market: Regional movement analysis
• Fig. 47 Global clinical trial equipment & ancillary solutions market: Regional outlook and key takeaways
• Fig. 48 Global clinical trial equipment & ancillary solutions market share and leading players
• Fig. 49 North America market share and leading players
• Fig. 50 Europe market share and leading players
• Fig. 51 Asia Pacific market share and leading players
• Fig. 52 Latin America market share and leading players
• Fig. 53 Middle East & Africa market share and leading players
• Fig. 54 North America, by country
• Fig. 55 North America
• Fig. 56 North America market estimates and forecasts, 2018 - 2030
• Fig. 57 U.S.
• Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 59 Canada
• Fig. 60 Canada market estimates and forecasts, 2018 - 2030
• Fig. 61 Europe
• Fig. 62 Europe market estimates and forecasts, 2018 - 2030
• Fig. 63 UK
• Fig. 64 UK market estimates and forecasts, 2018 - 2030
• Fig. 65 Germany
• Fig. 66 Germany market estimates and forecasts, 2018 - 2030
• Fig. 67 France
• Fig. 68 France market estimates and forecasts, 2018 - 2030
• Fig. 69 Italy
• Fig. 70 Italy market estimates and forecasts, 2018 - 2030
• Fig. 71 Spain
• Fig. 72 Spain market estimates and forecasts, 2018 - 2030
• Fig. 73 Denmark
• Fig. 74 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 75 Sweden
• Fig. 76 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 77 Norway
• Fig. 78 Norway market estimates and forecasts, 2018 - 2030
• Fig. 79 Asia Pacific
• Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 81 China
• Fig. 82 China market estimates and forecasts, 2018 - 2030
• Fig. 83 Japan
• Fig. 84 Japan market estimates and forecasts, 2018 - 2030
• Fig. 85 India
• Fig. 86 India market estimates and forecasts, 2018 - 2030
• Fig. 87 Thailand
• Fig. 88 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 89 South Korea
• Fig. 90 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 91 Australia
• Fig. 92 Australia market estimates and forecasts, 2018 - 2030
• Fig. 93 Latin America
• Fig. 94 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 95 Brazil
• Fig. 96 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 97 Mexico
• Fig. 98 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 99 Argentina
• Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 101 Colombia
• Fig. 102 Colombia market estimates and forecasts, 2018 - 2030
• Fig. 103 Middle East and Africa
• Fig. 104 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 105 South Africa
• Fig. 106 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 107 Saudi Arabia
• Fig. 108 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 109 UAE
• Fig. 110 UAE market estimates and forecasts, 2018 - 2030
• Fig. 111 Kuwait
• Fig. 112 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 113 Market share of key market players - Clinical trial equipment & ancillary solutions market

Clinical Trial Equipment & Ancillary Solutions Market Growth & Trends:

The global clinical trial equipment & ancillary solutions market size is expected to reach USD 5.10 billion by 2030, expanding at a CAGR of 8.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market. However, the COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments were in progress before the pandemic was halted due to COVID-19 globally. However, the growing demand for new and better treatment options has improved the number of clinical trial in the post-pandemic.

The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.

The pandemic has created a need for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques. Such adoptions are likely to propel market growth. Moreover, the high R&D spending by the pharmaceutical company for developing innovative therapies for COVID-19 has further contributed to the market growth.

Clinical Trial Equipment & Ancillary Solutions Market Report Highlights:

• The supply/logistics product segment dominated the market with a revenue share of more than 38.95% in 2023 due to the high number of clinical trials globally, which resulted in increased demand for efficient logistics services
• The phase III segment dominated the market in 2023 and is expected to maintain its dominance through 2030. Phase III studies are the most effective approach to discovering a new treatment standard
• North America led the global market in 2022 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region
• Asia Pacific is anticipated to witness fastest growth in the clinical trial equipment and ancillary solutions market during the forecast period as it is becoming an increasingly significant site for clinical trial investigations

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Phase
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Phase outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Evolving Clinical Trials Needs
    • 3.2.1.2. Rising Investment in R&D
    • 3.2.1.3. Growing pharmaceutical & Medical Devices industry
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Rising Cost of Clinical Trials
• 3.3. Clinical Trial Equipment & Ancillary Solutions Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
  • 3.3.2. PESTEL Analysis

Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
  • 4.4.1. Sourcing
    • 4.4.1.1. Sourcing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2. Procurement
    • 4.4.1.2.1. Procurement market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2.2. Equipment
    • 4.4.1.2.2.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2.3. Ancillaries
    • 4.4.1.2.3.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3. Rental
    • 4.4.1.3.1. Rental market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3.1.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3.2. Ancillaries
    • 4.4.1.3.2.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Supply/ Logistics
    • 4.4.2.1. Supply/logistics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.2. Transportation
    • 4.4.2.2.1. Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.3. Packaging
    • 4.4.2.3.1. Packaging market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.4. Others
    • 4.4.2.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Service
    • 4.4.3.1. Service market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.2. Calibrations
    • 4.4.3.2.1. Calibrations market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.3. Equipment Servicing
    • 4.4.3.3.1. Equipment servicing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.4. Others
    • 4.4.3.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

• 5.1. Phase Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Phase Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
  • 5.4.1. Phase I
    • 5.4.1.1. Phase I market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Phase II
    • 5.4.2.1. Phase II market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Phase III
    • 5.4.3.1. Phase III market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Phase IV
    • 5.4.4.1. Phase IV market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. Colombia
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Colombia market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Ancillare, LP
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Imperial CRS, Inc.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Woodley Equipment Company Ltd.
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Thermo Fisher Scientific, Inc.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Parexel International (MA) Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Emsere (MediCapital Rent)
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Quipment SAS
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. IRM
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Marken
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Myonex
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. Yourway
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives